English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
×
Site Menu
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
1 week ago
6
News24 | GNU hits new crisis as shock tax hike looms
Share this via
Finance Minister Enoch Godongwana, who has avoided tax hikes thus far, has now suggested to the Cabinet that an increase could be necessary.
Read Entire Article
Homepage
Headlines
News24 | GNU hits new crisis as shock tax hike looms
From Twitter
Related
College basketball team evacuates bus before it goes up in f...
42 minutes ago
0
Noem ends Biden-era use of controversial app to allow migran...
47 minutes ago
0
Top federal agency takes DOGE's mission to heart with all-ha...
56 minutes ago
0
Ramaswamy officially launches gubernatorial campaign in Ohio...
1 hour ago
0
Comments
Trending
1.
Joel Embiid
2.
Apple 500 billion investment
3.
Apple Stock
4.
Al Trautwig
5.
Harrison Ford
6.
NVIDIA Stock
7.
Oscars
8.
Meta stock
9.
Lester Holt
10.
Palantir stock
Popular News
Trump administration fires more than a dozen immigration jud...
1 week ago
238
Trump administration fires more than a dozen immigration judges
Share this via
Hamas hands over three Israeli captives in sixth phase of pr...
1 week ago
38
Hamas hands over three Israeli captives in sixth phase of prisoner exchange
Share this via
Why has a former Tory MP decide to serve in Ukraine’s milita...
1 week ago
35
Why has a former Tory MP decide to serve in Ukraine’s military? | BBC News
Share this via
'Cobra Kai' is a rare show that kids and adults both enjoy: ...
1 week ago
26
'Cobra Kai' is a rare show that kids and adults both enjoy: 'That's the really cool thing about' the...
Share this via
ASCO GU|RemeGen Announced Highly Encouraging Data from the P...
1 week ago
20
ASCO GU|RemeGen Announced Highly Encouraging Data from the Phase II Clinical Trial Evaluating Disita...
Share this via
Comments